Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MOTIV BTK Randomized Controlled Trial

NCT: NCT05406622 · ACTIVE_NOT_RECRUITING

NCT IDNCT05406622

StatusACTIVE_NOT_RECRUITING

Start Date2022-06-10

Completion2030-03-31

SponsorREVA Medical, Inc. (INDUSTRY)

First posted2022-06-06

Last updated2026-06-18

Brief Summary

Pre-market clinical evaluation of the MOTIV Sirolimus-Eluting Bioresorbable Scaffold for the planned treatment of infrapopliteal lesions.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑